This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, J. M.
Right arrow Articles by Cheng, A. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, J. M.
Right arrow Articles by Cheng, A. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2003, p. 3567-3573, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3567-3573.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Mutations in Topoisomerase Genes of Fluoroquinolone-Resistant Salmonellae in Hong Kong

J. M. Ling,* E. W. Chan, A. W. Lam, and A. F. Cheng

Department of Microbiology, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

Received 31 March 2003/ Returned for modification 15 May 2003/ Accepted 22 August 2003

A total of 88 salmonella isolates (72 clinical isolates for which the ciprofloxacin MIC was >0.06 µg/ml, 15 isolates for which the ciprofloxacin MIC was <=0.06 µg/ml, and Salmonella enterica serotype Typhimurium ATCC 13311) were studied for the presence of genetic alterations in four quinolone resistance genes, gyrA, gyrB, parC, and parE, by multiplex PCR amplimer conformation analysis. The genetic alterations were confirmed by direct nucleotide sequencing. A considerable number of strains had a mutation in parC, the first to be reported in salmonellae. Seven of the isolates sensitive to 0.06 µg of ciprofloxacin per ml had a novel mutation at codon 57 of parC (Tyr57->Ser) which was also found in 29 isolates for which ciprofloxacin MICs were >0.06 µg/ml. Thirty-two isolates had a single gyrA mutation (Ser83->Phe, Ser83->Tyr, Asp87->Asn, Asp87->Tyr, or Asp87->Gly), 34 had both a gyrA mutation and a parC mutation (29 isolates with a parC mutation of Tyr57->Ser and 5 isolates with a parC mutation of Ser80->Arg). Six isolates which were isolated recently (from 1998 to 2001) were resistant to 4 µg of ciprofloxacin per ml. Two of these isolates had double gyrA mutations (Ser83->Phe and Asp87->Asn) and a parC mutation (Ser80->Arg) (MICs, 8 to 32 µg/ml), and four of these isolates had double gyrA mutations (Ser83->Phe and Asp87->Gly), one parC mutation (Ser80->Arg), and one parE mutation (Ser458->Pro) (MICs, 16 to 64 µg/ml). All six of these isolates and those with a Ser80->Arg parC mutation were S. enterica serotype Typhimurium. One S. enterica serotype Typhi isolate harbored a single gyrA mutation (Ser83->Phe), and an S. enterica serotype Paratyphi A isolate harbored a gyrA mutation (Ser83->Tyr) and a parC mutation (Tyr57->Ser); both of these isolates had decreased susceptibilities to the fluoroquinolones. The MICs of ciprofloxacin, levofloxacin, and sparfloxacin were in general the lowest of those of the six fluoroquinolones tested. Isolates with a single gyrA mutation were less resistant to fluoroquinolones than those with an additional parC mutation (Tyr57->Ser or Ser80->Arg), while those with double gyrA mutations were more resistant.

* Corresponding author. Mailing address: Department of Microbiology, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China. Phone: (852) 2632 3333. Fax: (852) 2647 3227. E-mail: meilunling{at}cuhk.edu.hk.

Antimicrobial Agents and Chemotherapy, November 2003, p. 3567-3573, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3567-3573.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • O'Regan, E., Quinn, T., Pages, J.-M., McCusker, M., Piddock, L., Fanning, S. (2009). Multiple Regulatory Pathways Associated with High-Level Ciprofloxacin and Multidrug Resistance in Salmonella enterica Serovar Enteritidis: Involvement of ramA and Other Global Regulators. Antimicrob. Agents Chemother. 53: 1080-1087 [Abstract] [Full Text]  
  • Zheng, J., Cui, S., Meng, J. (2009). Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother 63: 95-102 [Abstract] [Full Text]  
  • Cui, S., Li, J., Sun, Z., Hu, C., Jin, S., Li, F., Guo, Y., Ran, L., Ma, Y. (2009). Characterization of Salmonella enterica isolates from infants and toddlers in Wuhan, China. J Antimicrob Chemother 63: 87-94 [Abstract] [Full Text]  
  • Akiba, M., Nakaoka, Y., Kida, M., Ishioka, Y., Sameshima, T., Yoshii, N., Nakazawa, M., Uchida, I., Terakado, N. (2007). Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005. J Antimicrob Chemother 60: 1235-1242 [Abstract] [Full Text]  
  • Chau, T. T., Campbell, J. I., Galindo, C. M., Van Minh Hoang, N., Diep, T. S., Nga, T. T. T., Van Vinh Chau, N., Tuan, P. Q., Page, A. L., Ochiai, R. L., Schultsz, C., Wain, J., Bhutta, Z. A., Parry, C. M., Bhattacharya, S. K., Dutta, S., Agtini, M., Dong, B., Honghui, Y., Anh, D. D., Canh, D. G., Naheed, A., Albert, M. J., Phetsouvanh, R., Newton, P. N., Basnyat, B., Arjyal, A., La, T. T. P., Rang, N. N., Phuong, L. T., Van Be Bay, P., von Seidlein, L., Dougan, G., Clemens, J. D., Vinh, H., Hien, T. T., Chinh, N. T., Acosta, C. J., Farrar, J., Dolecek, C. (2007). Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones. Antimicrob. Agents Chemother. 51: 4315-4323 [Abstract] [Full Text]  
  • Solnik-Isaac, H., Weinberger, M., Tabak, M., Ben-David, A., Shachar, D., Yaron, S. (2007). Quinolone Resistance of Salmonella enterica Serovar Virchow Isolates from Humans and Poultry in Israel: Evidence for Clonal Expansion. J. Clin. Microbiol. 45: 2575-2579 [Abstract] [Full Text]  
  • Chen, S., Cui, S., McDermott, P. F., Zhao, S., White, D. G., Paulsen, I., Meng, J. (2007). Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials. Antimicrob. Agents Chemother. 51: 535-542 [Abstract] [Full Text]  
  • Gaind, R., Paglietti, B., Murgia, M., Dawar, R., Uzzau, S., Cappuccinelli, P., Deb, M., Aggarwal, P., Rubino, S. (2006). Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 58: 1139-1144 [Abstract] [Full Text]  
  • Saha, S. K., Darmstadt, G. L., Baqui, A. H., Crook, D. W., Islam, M. N., Islam, M., Hossain, M., El Arifeen, S., Santosham, M., Black, R. E. (2006). Molecular Basis of Resistance Displayed by Highly Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Bangladesh.. J. Clin. Microbiol. 44: 3811-3813 [Abstract] [Full Text]  
  • Izumiya, H., Mori, K., Kurazono, T., Yamaguchi, M., Higashide, M., Konishi, N., Kai, A., Morita, K., Terajima, J., Watanabe, H. (2005). Characterization of Isolates of Salmonella enterica Serovar Typhimurium Displaying High-Level Fluoroquinolone Resistance in Japan. J. Clin. Microbiol. 43: 5074-5079 [Abstract] [Full Text]  
  • Randall, L. P., Coldham, N. G., Woodward, M. J. (2005). Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation. J Antimicrob Chemother 56: 619-623 [Abstract] [Full Text]  
  • Randall, L. P., Eaves, D. J., Cooles, S. W., Ricci, V., Buckley, A., Woodward, M. J., Piddock, L. J. V. (2005). Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression. J Antimicrob Chemother 56: 297-306 [Abstract] [Full Text]  
  • Murray, A., Coia, J. E., Mather, H., Brown, D. J. (2005). Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003. J Antimicrob Chemother 56: 110-114 [Abstract] [Full Text]  
  • Baucheron, S., Chaslus-Dancla, E., Cloeckaert, A., Chiu, C.-H., Butaye, P. (2005). High-Level Resistance to Fluoroquinolones Linked to Mutations in gyrA, parC, and parE in Salmonella enterica Serovar Schwarzengrund Isolates from Humans in Taiwan. Antimicrob. Agents Chemother. 49: 862-863 [Full Text]  
  • Olliver, A., Valle, M., Chaslus-Dancla, E., Cloeckaert, A. (2005). Overexpression of the Multidrug Efflux Operon acrEF by Insertional Activation with IS1 or IS10 Elements in Salmonella enterica Serovar Typhimurium DT204 acrB Mutants Selected with Fluoroquinolones. Antimicrob. Agents Chemother. 49: 289-301 [Abstract] [Full Text]  
  • Eaves, D. J., Randall, L., Gray, D. T., Buckley, A., Woodward, M. J., White, A. P., Piddock, L. J. V. (2004). Prevalence of Mutations within the Quinolone Resistance-Determining Region of gyrA, gyrB, parC, and parE and Association with Antibiotic Resistance in Quinolone-Resistant Salmonella enterica. Antimicrob. Agents Chemother. 48: 4012-4015 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»